GLP-1
Glucagon-like peptide 1(7-36)amide (GLP-1), an intestinally derived       insulinotropic hormone, represents a potential therapeutic agent for type 2       diabetes, because exogenous GLP-1 has been shown to increase the insulin and       reduce the glucagon concentrations in these patients, and thus induce lower blood       glucose, but without causing hypoglycemia.
Glucagon-like peptide 1(7-36)amide (GLP-1), an intestinally derived       insulinotropic hormone, represents a potential therapeutic agent for type 2       diabetes, because exogenous  @SUBJECT$  has been shown to  @PREDICAT$  the  @OBJECT$  and       reduce the glucagon concentrations in these patients, and thus induce lower blood       glucose, but without causing hypoglycemia.